or
forgot password
  • cancer clinical trials in baltimore, MD

  • Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Greenebaum Cancer Center at University of Maryland Medical Center
    Baltimore, Maryland 21201
    Prostate Cancer
    STEPP: A Phase 2, Open-label, Randomized Clinical Trial of Skin Toxicity Treatment in mCRC Subjects Receiving Panitumumab Concomitantly With Second-line Irinotecan Based Chemotherapy
    Research Site
    Baltimore, Maryland
    Metastatic Colorectal Cancer, Skin Rash, Skin Toxicities, Colon Cancer, Colorectal Cancer
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Trial Locations
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
    Kidney Cancer
    Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
    Johns Hopkins University
    Baltimore, Maryland 21205
    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.
    Research Center In
    Baltimore, Maryland
    Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer
    DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    Sinai Hospital of Baltimore
    University of Maryland, Baltimore
    Lung Cancer
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    Sinai Hospital of Baltimore
    University of Maryland Greenebaum Cancer Center
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
    Sinai Hospital of Baltimore

    Trial Locations
    Sinai Hospital of Baltimore
    University of Maryland Greenebaum Cancer Center
    Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    Sinai Hospital of Baltimore

    Trial Locations
    Sinai Hospital of Baltimore
    University of Maryland Greenebaum Cancer Center
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Johns Hopkins University
    Baltimore, Maryland 21205
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Myelodysplastic Syndromes
    Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Leukemia
    Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
    University of Maryland Greenebaum Cancer Center
    Baltimore, Maryland 21201
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Regional Transitional Cell Cancer of the Renal Pelvis and Ureter, Stage III Bladder Cancer, Stage IV Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer, Urethral Cancer Associated With Invasive Bladder Cancer
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Trial Locations
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
    Leukemia, Myelodysplastic Syndromes
    Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Trial Locations
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
    Greenebaum Cancer Center at University of Maryland Medical Center
    Leukemia
    Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation
    University of Maryland, Greenbaum Cancer Center
    Baltimore, Maryland 21201
    Chronic Myeloid Leukemia
    Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
    Kaiser Permanente at Woodlawn Medical Center
    Baltimore, Maryland 21244
    Breast Cancer, Lymphedema, Perioperative/Postoperative Complications
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Sinai Hospital of Baltimore

    Trial Locations
    Sinai Hospital of Baltimore
    Greater Baltimore Medical Center
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    Sinai Hospital of Baltimore
    University of Maryland Greenebaum Cancer Center
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
    Baltimore, Maryland 21215
    Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Harry & Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center

    Trial Locations
    Harry & Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center
    Greater Baltimore Medical Center Cancer Center
    Mercy Medical Center
    St. Agnes Hospital Cancer Center
    Breast Cancer
    Azacitidine and MS-275 in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    Johns Hopkins Bayview Medical Center
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    University of Maryland Greenebaum Cancer Center
    Baltimore, Maryland 21201
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    University of Maryland Greenebaum Cancer Center
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Study of ATN-224 in Patients With Prostate Cancer
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
    Baltimore, Maryland 21231
    Prostate Cancer